Multicenter phase II trial evaluating a three-weekly schedule of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancer-Reference-Cited by-同舟云学术

Multicenter phase II trial evaluating a three-weekly schedule of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancer

Published:2003-07 Issue:7 Volume:14 Page:1121-1125
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Aparicio J.,Vicent J.M.,Maestu I.,Garcerá S.,Busquier I.,Bosch C.,Llorca C.,Díaz R.,Fernández-Martos C.,Galán A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/7/1121/324899/mdg285.pdf

Reference29 articles.

1. CPT-11 (irinotecan) in the treatment of colorectal cancer;Armand;Eur J Cancer,1995

2. Irinotecan is an active agent in untreated patients with metastatic colorectal cancer;Conti;J Clin Oncol,1996

3. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer;Rothenberg;J Clin Oncol,1996

4. Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy;Rougier;J Clin Oncol,1997

5. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer;Cunningham;Lancet,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study;BMC Cancer;2024-09-02

2. Irinotecan plus raltitrexed as second‑line chemotherapy for metastatic colorectal cancer: A retrospective study;Oncology Letters;2024-06-28

3. Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multicenter, Phase II study;2024-02-14

4. A Preliminary Study of Immediate Intraperitoneal Chemotherapy for Stage III Colorectal Cancer;American Journal of Clinical Oncology;2023-03-30

5. Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial;Journal of Gastrointestinal Oncology;2022-06